Macromolecular Therapeutics: Emerging Strategies for Drug Discovery in the Postgenome Era
R.L. Juliano, A. Astriab-Fisher, and D. Falke
Mol Interv April 2001 1:40-53
Characterizing Proteins of Unknown Function: Orphan Cytochrome P450 Enzymes as a Paradigm
F. Peter Guengerich, Zhongmei Tang, S. Giovanna Salamanca-Pinzón, and Qian Cheng
Mol Interv June 2010 10:153-163; doi:10.1124/mi.10.3.6
Systemic Administration of Naked DNA: Gene Transfer to Skeletal Muscle
Feng Liu, Kenneth W. Liang, and Leaf Huang
Mol Interv August 2001 1:168-172
Expression Array Technology in the Diagnosis and Treatment of Breast Cancer
Stefanie S. Jeffrey, Michael J. Fero, Anne-Lise Børresen-Dale, and David Botstein
Mol Interv April 2002 2:101-109; doi:10.1124/mi.2.2.101
Small Interfering RNAs: A Revolutionary Tool for the Analysis of Gene Function and Gene Therapy
Thomas Tuschl and Arndt Borkhardt
Mol Interv June 2002 2:158-167; doi:10.1124/mi.2.3.158
Caenorhabditis elegans in Parkinson’s Disease Drug Discovery: Addressing an Unmet Medical Need
Richard Nass, Kalpana M. Merchant, and Timothy Ryan
Mol Interv December 2008 8:284-293; doi:10.1124/mi.8.6.6
Pharmacokinetic Assessment of Multiple ATP-binding Cassette Transporters: The Power of Combination Knockout Mice
Jurjen S. Lagas, Maria L.H. Vlaming, and Alfred H. Schinkel
Mol Interv June 2009 9:136-145; doi:10.1124/mi.9.3.7
Drosophila: A “Model” Model System To Study Neurodegeneration
Alicia M. Celotto and Michael J. Palladino
Mol Interv October 2005 5:292-303; doi:10.1124/mi.5.5.9
Regenerative Pharmacology: The Future is Now
Karl-Erik Andersson and George J. Christ
Mol Interv April 2007 7:79-86; doi:10.1124/mi.7.2.8
Translational NeuroImaging of the CNS: Novel Pathways to Drug Development
Gerard B. Fox, Chih-Liang Chin, Feng Luo, Mark Day, and Bryan F. Cox
Mol Interv December 2009 9:302-313; doi:10.1124/mi.9.6.6
Serotonin 5-HT2 Receptors: Molecular and Genomic Diversity
Elaine Sanders-Bush, Hugh Fentress, and Lisa HazelwoodMolecular
Mol Interv September 2003 3:319-330; doi:10.1124/mi.3.6.319
Biochemical Mechanisms of Cyclosporine Neurotoxicity
Natalie J. Serkova, Uwe Christians, and Leslie Z. Benet
Mol Interv April 2004 4:97-107; doi:10.1124/mi.4.2.7
Antibody Conjugates and Therapeutic Strategies
Paul A. McCarron, Shane A. Olwill, Waleed M.Y. Marouf, Richard J. Buick, Brian Walker, and Christopher J. Scott
Mol Interv December 2005 5:368-380; doi:10.1124/mi.5.6.9
Regulation of Receptors and Transporters by Ubiquitination: New Insights into Surprisingly Similar Mechanisms
Manuel Miranda and Alexander Sorkin
Mol Interv June 2007 7:157-167; doi:10.1124/mi.7.3.7
Recombinant Pharmaceuticals from Plants: The Plant Endomembrane System as Bioreactor
Alessandro Vitale and Emanuela Pedrazzini
Mol Interv August 2005 5:216-225; doi:10.1124/mi.5.4.5
Networking with AKAPs: Context-dependent Regulation of Anchored Enzymes
Emily J. Welch, Brian W. Jones, and John D. Scott
Mol Interv April 2010 10:86-97; doi:10.1124/mi.10.2.6
The Biology of Caveolae: Lessons from Caveolin Knockout Mice and Implications for Human Disease
Robert Hnasko and Michael P. Lisanti
Mol Interv December 2003 3:445-464; doi:10.1124/mi.3.8.445